27th April Iacopo Bicci-

Joana Domingues- “Mitochondrial DNA methylation in health and disease” From the gut to the brain: α-synuclein pathology spreading in a new transgenic mouse model 4th May Marco Eagle-

Mary Goodwin- ‘Imaging biomarkers for predicting cognitive decline and dementia in small vessel disease patients’

Developing an hiPSC-derived 3D in vitro model of the blood brain barrier to study monogenic forms of cerebral small vessel disease 11th May Hani Mousa- LIGHT (TNFSF14) Signalling in Multiple Sclerosis

18th May Maura Malpetti- Luca Passamonti- Decline and fall in degenerative tauopathies A new noradrenergic strategy to treat impulsivity in progressive supranuclear palsy 25th May Shamma Qarin-

Tereza Vargova- TBC

‘The role of the medial entorhinal cortex in navigation and its involvement in Alzheimer’s disease’ 1st June Alice White-

Sarita Deshpande- Neural correlates of decision-making in Huntington’s Disease

Therapies for Optic Nerve Regeneration 8th June Christopher Wickens- Zoe Alder-first “In vivo MRS pulse sequence development for tracking cerebral metabolism in TBI patients EEG correlates of entorhinal cortex dysfunction in MCI 15th June Naomi Deakin- Michael Whitehead- ‘Development of a Novel Gene Therapy for Diabetic Retinopathy’ 22nd June Jennifer Jia-

Andrea Luppi- Activity-dependence of myelination

Relating Entropy and Integration in Anaesthesia and Disorders of Consciousness 19th June Terrance Mensah-

Thomas Varley- Highlighting the benefit of a dual vector construct (AAV2 TrkB-2A-mBDNF) over receptor (TRkB) or ligand (mBDNF) alone vectors

‘Fractal Dimension as a Measure of Complexity & Consciousness in Disorders of Consciousness & Psychedelic Drugs’

6th July Regan Hamel- David Nesbitt scRNA-seq Analysis of Non-Neuronal Cells After Traumatic SCI